Home Applications 020668 Application 020668
Type NDA
Sponsor ASTRAZENECA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LEXXEL ENALAPRIL MALEATE; FELODIPINE TABLET, EXTENDED RELEASE;ORAL 5MG;5MG No No 002 LEXXEL ENALAPRIL MALEATE; FELODIPINE TABLET, EXTENDED RELEASE;ORAL 5MG;2.5MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020668-001 LEXXEL ENALAPRIL MALEATE; FELODIPINE 5MG;5MG TABLET, EXTENDED RELEASE / ORAL 1996-12-27 N020668-002 LEXXEL ENALAPRIL MALEATE; FELODIPINE 5MG;2.5MG TABLET, EXTENDED RELEASE / ORAL 1998-10-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N020668-001 LEXXEL 5MG;5MG TABLET, EXTENDED RELEASE / ORAL 1996-12-27 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N020668-002 LEXXEL 5MG;2.5MG TABLET, EXTENDED RELEASE / ORAL 1998-10-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020668-001 LEXXEL 5MG;5MG TABLET, EXTENDED RELEASE / ORAL 1996-12-27 e64feba35796…2022-09-29 23:25 UTC 2022-09 N020668-002 LEXXEL 5MG;2.5MG TABLET, EXTENDED RELEASE / ORAL 1998-10-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020668-001 LEXXEL 5MG;5MG TABLET, EXTENDED RELEASE / ORAL 1996-12-27 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020668-002 LEXXEL 5MG;2.5MG TABLET, EXTENDED RELEASE / ORAL 1998-10-28 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020668-001 LEXXEL 5MG;5MG TABLET, EXTENDED RELEASE / ORAL 1996-12-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020668-002 LEXXEL 5MG;2.5MG TABLET, EXTENDED RELEASE / ORAL 1998-10-28 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 20812 SUPPL 2008-02-19 3051 SUPPL 2007-10-10 41535 SUPPL 2007-07-06 20810 SUPPL 2007-07-06 13177 SUPPL 2005-08-04 3048 SUPPL 2005-08-04 3050 SUPPL 2004-12-29 25483 SUPPL 2004-06-10 13178 SUPPL 2004-06-10 3049 SUPPL 2003-06-22 20811 SUPPL 2002-07-25 35119 SUPPL 1998-10-28 3047 SUPPL 1998-10-28